1. Home
  2. VERX vs TYRA Comparison

VERX vs TYRA Comparison

Compare VERX & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertex Inc.

VERX

Vertex Inc.

N/A

Current Price

$13.67

Market Cap

2.2B

Sector

Technology

ML Signal

N/A

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

N/A

Current Price

$26.16

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VERX
TYRA
Founded
1978
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.0B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
VERX
TYRA
Price
$13.67
$26.16
Analyst Decision
Buy
Strong Buy
Analyst Count
12
11
Target Price
$24.25
$47.50
AVG Volume (30 Days)
2.4M
591.8K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$748,444,000.00
N/A
Revenue This Year
$12.78
N/A
Revenue Next Year
$11.61
N/A
P/E Ratio
$302.25
N/A
Revenue Growth
12.25
N/A
52 Week Low
$10.21
$11.82
52 Week High
$26.54
$40.65

Technical Indicators

Market Signals
Indicator
VERX
TYRA
Relative Strength Index (RSI) 59.16 41.86
Support Level $11.52 $24.72
Resistance Level $14.98 $27.06
Average True Range (ATR) 0.57 1.47
MACD 0.14 0.01
Stochastic Oscillator 94.22 28.61

Price Performance

Historical Comparison
VERX
TYRA

About VERX Vertex Inc.

Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. It provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting, among others. The company derives revenue from software subscriptions.

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Share on Social Networks: